Moreover, upon TCGA database, cervical cancer patients with high PRMT5 expression were found to have a significantly worse overall survival (OS), progression free interval (PFI) and disease free interval (DFI) (Figure 1D). This evidence concerns the gene PRMT5 and cervical cancer.